Supreme Court gives Merck another shot to avoid Fosamax lawsuits
The U.S. Supreme Court on Monday gave Merck & Co a new opportunity to avoid lawsuits accusing the company of failing to properly warn patients of debilitating thigh-bone fractures from taking its osteoporosis drug Fosamax, throwing out a lower court decision that had revived the litigation.
from Reuters: Health News https://reut.rs/2LTupkK
http://bit.ly/2zwRqiM
May 20, 2019
|
Labels:
health,
Reuters: Health News
|
This entry was posted on May 20, 2019
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.